These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 4850682

  • 21. Investigations on correlations between serum enzymes and histological findings in liver disease. With special reference to transaminases and urocanase.
    Trip JA, van Dam J, Eibergen R, Que GS.
    Acta Med Scand; 1973; 193(1-2):113-8. PubMed ID: 4145127
    [No Abstract] [Full Text] [Related]

  • 22. [Australia antigen in chronic aggressive hepatitis and liver cirrhosis. Its significance for the etiology and pathogenesis of chronic inflammatory liver diseases].
    Müller R, Kalden JR, Baruth B, Deicher H.
    Dtsch Med Wochenschr; 1972 Mar 10; 97(10):369-75. PubMed ID: 4622158
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Significance of serum complement levels in chronic liver disease.
    Finlayson ND, Krohn K, Fauconnet MH, Anderson KE.
    Gastroenterology; 1972 Oct 10; 63(4):653-9. PubMed ID: 4116547
    [No Abstract] [Full Text] [Related]

  • 25. Asymptomatic liver disease in Australia-antigen-positive blood donors.
    Woolf IL, Boyes BE, Dymock IW, Renton PH, Stratton F.
    Gut; 1972 Oct 10; 13(10):852. PubMed ID: 5087112
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.
    Dudley FJ, O'Shea MJ, Sherlock S.
    Clin Exp Immunol; 1973 Mar 10; 13(3):367-72. PubMed ID: 4349710
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].
    Bertrams J, Kuwert E, Reis HE, Selmair H, Wiese W.
    Zentralbl Bakteriol Orig A; 1974 Mar 10; 227(1-4):372-7. PubMed ID: 4154614
    [No Abstract] [Full Text] [Related]

  • 30. Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers.
    Bolin TD, Davis AE, Liddelow AG.
    Gut; 1973 May 10; 14(5):365-8. PubMed ID: 4716503
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The etiology of chronic active hepatitis in Korea.
    Prince AM, Gershon RK.
    Yale J Biol Med; 1979 May 10; 52(2):159-67. PubMed ID: 377825
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Studies on juvenile chronic hepatitis].
    Feist D.
    Fortschr Med; 1975 Sep 11; 93(25):1154-8. PubMed ID: 55374
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.